Novel Mobile Device Application to Improve Adherence
Public ClinicalTrials.gov record NCT02904278. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Controlled Trial of a Novel Mobile Device Application to Improve Adherence in Children Greater Than 11 Years of Age After Cardiac Transplantation (CTOTC-10)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to collect and compare information on how and when adolescent heart transplant recipients take their prescribed medication. The investigators want to find out if regular use of 'an app' on cell phones, called the Teen Pocket PATH® (TPP), can help adolescents take their medication according to their prescribed dosing schedule. This may then help reduce complications of transplant, such as rejection. The investigators also want to find out if how adolescent heart transplant recipients take their medications affects the development of antibodies in their blood. Antibodies are small proteins in the blood that may develop after heart transplantation, and which can sometimes damage a new heart.
Study identification
- NCT ID
- NCT02904278
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Interventions
Other
Eligibility (public fields only)
- Age range
- 11 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 9, 2017
- Primary completion
- Oct 31, 2019
- Completion
- Oct 31, 2019
- Last update posted
- Dec 3, 2019
2017 – 2019
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Emory University School of Medicine: Pediatric Transplantation | Atlanta | Georgia | 30060 | — |
| Boston Children's Hospital: Pediatric Transplantation | Boston | Massachusetts | 02115 | — |
| St. Louis Children's Hospital: Pediatric Transplantation | St Louis | Missouri | 63110 | — |
| Columbia University Medical Center: Pediatric Transplantation | New York | New York | 10032 | — |
| Montefiore Medical Center: Pediatric Transplantation | New York | New York | 10467 | — |
| Children's Hospital of Philadelphia: Pediatric Transplantation | Philadelphia | Pennsylvania | 19104 | — |
| Children's Hospital of Pittsburgh: Pediatric Transplantation | Pittsburgh | Pennsylvania | 15224 | — |
| Monroe Carell Jr. Children's Hospital at Vanderbilt: Pediatric Transplantation | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02904278, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2019 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02904278 live on ClinicalTrials.gov.